Summary:
A Double-Blind, Randomized, Placebo-Controlled Study for the Safety and Efficacy of a Stuttering Therapy for Adults.
Qualified Participants Must:
• Adults age 18-65 with self-reported or diagnosed condition of stuttering, speech impairment, speech disorder, speech impediment, or nervous stuttering.
Qualified Participants May Receive:
Eligible participants may recieve compensation for study participation. Clinic may provide transportation.